Candel Therapeutics, Inc. (CADL)
11.59
-0.58
(-4.77%)
USD |
NASDAQ |
Sep 10, 12:28
Candel Therapeutics Price to Book Value : 6.994 for Sept. 10, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 09, 2026 | 7.344 |
| September 08, 2026 | 7.604 |
| September 04, 2026 | 7.713 |
| September 03, 2026 | 7.827 |
| September 02, 2026 | 7.966 |
| September 01, 2026 | 7.755 |
| August 31, 2026 | 7.888 |
| August 28, 2026 | 7.888 |
| August 27, 2026 | 8.298 |
| August 26, 2026 | 8.014 |
| August 25, 2026 | 8.208 |
| August 24, 2026 | 7.761 |
| August 21, 2026 | 7.924 |
| August 20, 2026 | 7.453 |
| August 19, 2026 | 8.147 |
| August 18, 2026 | 7.272 |
| August 17, 2026 | 7.338 |
| August 14, 2026 | 7.073 |
| August 13, 2026 | 7.121 |
| August 12, 2026 | 6.445 |
| August 11, 2026 | 6.427 |
| August 10, 2026 | 6.337 |
| August 07, 2026 | 6.391 |
| August 06, 2026 | 6.385 |
| August 05, 2026 | 6.312 |
| Date | Value |
|---|---|
| August 04, 2026 | 6.343 |
| August 03, 2026 | 6.077 |
| July 31, 2026 | 6.041 |
| July 30, 2026 | 5.956 |
| July 29, 2026 | 5.673 |
| July 28, 2026 | 5.842 |
| July 27, 2026 | 6.011 |
| July 24, 2026 | 5.769 |
| July 23, 2026 | 5.950 |
| July 22, 2026 | 6.089 |
| July 21, 2026 | 6.168 |
| July 20, 2026 | 5.775 |
| July 17, 2026 | 6.144 |
| July 16, 2026 | 5.721 |
| July 15, 2026 | 5.818 |
| July 14, 2026 | 5.956 |
| July 13, 2026 | 5.818 |
| July 10, 2026 | 5.727 |
| July 09, 2026 | 5.968 |
| July 08, 2026 | 5.962 |
| July 07, 2026 | 5.944 |
| July 06, 2026 | 6.053 |
| July 02, 2026 | 5.932 |
| July 01, 2026 | 5.962 |
| June 30, 2026 | 6.216 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.627 |
| Alnylam Pharmaceuticals, Inc. | 24.72 |
| Anika Therapeutics, Inc. | 2.022 |
| Savara, Inc. | 7.606 |
| Vericel Corp. | 5.273 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0781 |
| Price | 11.59 |
| Earnings Yield | -12.16% |
| Market Cap | 882.21M |
| PEGY Ratio | -0.0781 |